United States · FDA National Drug Code directory
Gabapentin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 80425-0033_4d628103-5e90-0a21-e063-6394a90a484e
- Product NDC
- 80425-0033
- Form
- CAPSULE
- Composition / generic term
- Gabapentin
- Labeler
- Advanced Rx of Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110129
- Source listing expiry
- 20271231
Source-listed ingredients
- GABAPENTIN — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (80425-0033-1) · 80425-0033-1
- 60 CAPSULE in 1 BOTTLE (80425-0033-2) · 80425-0033-2
- 90 CAPSULE in 1 BOTTLE (80425-0033-3) · 80425-0033-3
- 40 CAPSULE in 1 BOTTLE (80425-0033-4) · 80425-0033-4
- 120 CAPSULE in 1 BOTTLE (80425-0033-5) · 80425-0033-5
- 9 CAPSULE in 1 BOTTLE (80425-0033-6) · 80425-0033-6
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →